Regeneron Pharmaceuticals Inc. buy JPMorgan Chase & Co.
Start price
02.08.24
/
50%
€990.00
Target price
02.08.25
€1,099.6
Performance (%)
-51.29%
End price
03.08.25
€482.20
Summary
This prediction ended on 03.08.25 with a price of €482.20. The BUY prediction by JPMorgan_Chase___Co_ for Regeneron Pharmaceuticals Inc. performed very badly with a performance of -51.29%. JPMorgan_Chase___Co_ has a follow-up prediction for Regeneron Pharmaceuticals Inc. where he still thinks Regeneron Pharmaceuticals Inc. is a Buy. Dividends of €1.72 are taken into consideration when calculating the performance. JPMorgan_Chase___Co_ has 50% into this predictionRegeneron Pharmaceuticals, Inc. is a biotechnology company that is engaged in the discovery, development, and commercialization of medicines for the treatment of serious medical conditions. The company's products include EYLEA, a treatment for wet age-related macular degeneration and diabetic macular edema; Dupixent, a treatment for atopic dermatitis and asthma; and Libtayo, a treatment for certain types of cancer. Regeneron also has a strong focus on research and development, with a pipeline of potential new treatments for a variety of diseases. The company is headquartered in Tarrytown, New York and trades on the NASDAQ stock exchange under the symbol REGN.
Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Regeneron Pharmaceuticals Inc. | 3.928% | 3.928% | -5.544% |
| iShares Core DAX® | -0.197% | -1.724% | 12.342% |
| iShares Nasdaq 100 | -3.612% | -3.768% | 0.437% |
| iShares Nikkei 225® | 1.176% | 2.165% | 19.971% |
| iShares S&P 500 | -0.825% | -1.916% | 0.099% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Regeneron Pharmaceuticals Inc. diskutieren
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) had its price target raised by analysts at JPMorgan Chase & Co. from $1,150.00 to $1,200.00. They now have an "overweight" rating on the stock.
Ratings data for REGN provided by MarketBeat
In the thread Trading Regeneron Pharmaceuticals Inc.
Die von JPMorgan_Chase___Co_ gewählte maximale Laufzeit wurde überschritten
Current prediction by JPMorgan_Chase___Co_ for Regeneron Pharmaceuticals Inc.
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€586.00
31.03.25
31.03.25
€922.40
31.03.26
31.03.26
13.86%
06.02.26
06.02.26
Stopped prediction by JPMorgan_Chase___Co_ for Regeneron Pharmaceuticals Inc.
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€639.20
02.02.26
02.02.26
€800.09
02.02.27
02.02.27
3.97%
06.02.26
06.02.26
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€444.50
09.06.25
09.06.25
€700.56
09.06.26
09.06.26
49.91%
06.02.26
06.02.26
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€872.60
24.10.24
24.10.24
€1,064.9
24.10.25
24.10.25
-42.87%
25.10.25
25.10.25
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€974.20
17.06.24
17.06.24
€1,072.3
17.06.25
17.06.25
-54.45%
18.06.25
18.06.25